ArticlePathology oncology research : POR2023

Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer.

Guohu Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.